Moderna Stock Crashes 18% Despite Promising Cancer Vaccine Results
Moderna stock suffered a brutal selloff after its cancer vaccine trial results emerged early.
Opens in a new tab. Cointrackx tracks this click for statistics.
Partner
Moderna stock suffered a brutal selloff after its cancer vaccine trial results emerged early.
Opens in a new tab. Cointrackx tracks this click for statistics.
Partner
Install the App
To install: tap the Share button, then tap Add to Home Screen.
Install the app for faster access and live updates.